浏览全部资源
扫码关注微信
1.重庆三峡医药高等专科学校基础医学部,重庆 404120
2.重庆市抗肿瘤天然药物工程研究中心,重庆 404120
3.三峡库区道地药材开发利用重庆市重点实验室,重庆 404120
Published:30 October 2023,
Received:05 April 2023,
Revised:03 September 2023,
扫 描 看 全 文
刘滢,谭辉,夏菁等.人参皂苷Rh2对胶质瘤细胞增殖、凋亡的影响及机制 Δ[J].中国药房,2023,34(20):2471-2475.
LIU Ying,TAN Hui,XIA Jing,et al.Effects and mechanism of ginsenoside Rh2 on the proliferation and apoptosis of human glioma cells[J].ZHONGGUO YAOFANG,2023,34(20):2471-2475.
刘滢,谭辉,夏菁等.人参皂苷Rh2对胶质瘤细胞增殖、凋亡的影响及机制 Δ[J].中国药房,2023,34(20):2471-2475. DOI: 10.6039/j.issn.1001-0408.2023.20.05.
LIU Ying,TAN Hui,XIA Jing,et al.Effects and mechanism of ginsenoside Rh2 on the proliferation and apoptosis of human glioma cells[J].ZHONGGUO YAOFANG,2023,34(20):2471-2475. DOI: 10.6039/j.issn.1001-0408.2023.20.05.
目的
2
探讨人参皂苷Rh
2
对人胶质瘤U87、U251细胞增殖、凋亡的影响及可能机制。
方法
2
以人胶质瘤U87、U251细胞为对象,经不同浓度的人参皂苷Rh
2
作用后,检测细胞的增殖、凋亡情况以及细胞中组蛋白脱乙酰酶1(HDAC1)蛋白和凋亡相关蛋白[B细胞淋巴瘤2(Bcl-2)、Bcl-2相关X蛋白(Bax)、切割型胱天蛋白酶3(cleaved caspase-3)]的表达情况。
结果
2
10、20、30、40、50、60、70、80 μmol/L的人参皂苷Rh
2
均能显著升高U87、U251细胞的增殖抑制率(
P
<0.05或
P
<0.01),该成分对2种细胞作用48 h的半数抑制浓度分别为51.34、55.84 μmol/L;30、50 μmol/L的人参皂苷Rh
2
均能显著升高2种细胞的总凋亡率,能显著降低HDAC1、Bcl-2蛋白的表达水平,并显著升高Bax、cleaved caspase-3蛋白的表达水平(
P
<0.05或
P
<0.01)。
结论
2
人参皂苷Rh
2
可抑制2种人胶质瘤细胞增殖并促进其凋亡,其作用可能与下调HDAC1蛋白的表达和激活Bcl-2家族蛋白介导的凋亡途径有关。
OBJECTIVE
2
To investigate the effects and mechanism of ginsenoside Rh
2
on the proliferation and apoptosis in human glioma U87 and U251 cells.
METHODS
2
Using human glioma U87 and U251 cells as subjects, the proliferation and apoptosis, as well as the expression of histone deacetylase 1 (HDAC1) protein and apoptosis-related proteins [B cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (Bax) and cleaved caspase-3] were detected after being treated with different concentrations of ginsenoside Rh
2
.
RESULTS
2
The concentrations of 10, 20, 30, 40, 50, 60, 70, 80 μmol/L ginsenoside Rh
2
could generally significantly increase the proliferation inhibition rate of U87 and U251 cells (
P
<0.05 or
P
<0.01), and the half inhibitory concentrations of this component after 48 hours of action were 51.34 and 55.84 μmol/L, respectively; 30, 50 μmol/L ginsenoside Rh
2
could increase the total apoptotic rate of both types of cells, reduced the protein expressions of HDAC1 and Bcl-2, and increased the protein expressions of Bax and cleaved caspase-3 significantly (
P
<0.05 or
P
<0.01).
CONCLUSIONS
2
Ginsenoside Rh
2
has a significant inhibitory effect on the proliferation of glioma cells and promotes the apoptosis of cells, which may be through reducing the expression of HDAC1 protein and activating the Bcl-2 family protein-mediated apoptosis pathway.
人参皂苷Rh2胶质瘤组蛋白脱乙酰基酶1U87细胞U251细胞增殖凋亡
ginsenoside Rh2gliomahistone deacetylase 1U87 cellsU251 cellsproliferationapoptosis
GRIMM S A,CHAMBERLAIN M C. Brainstem glioma:a review[J]. Curr Neurol Neurosci Rep,2013,13(5):346.
GUSYATINER O,HEGI M E. Glioma epigenetics:from subclassification to novel treatment options[J]. Semin Cancer Biol,2018,51:50-58.
CHEN X Y,QIAN F,WANG Y Y,et al. Ginsenoside 20(S)-Rh2 promotes cellular pharmacokinetics and intracellular antibacterial activity of levofloxacin against Staphylococcus aureus through drug efflux inhibition and subcellular stabilization[J]. Acta Pharmacol Sin,2021,42(11):1930-1941.
LI X,CHU S F,LIN M Y,et al. Anticancer property of ginsenoside Rh2 from ginseng[J]. Eur J Med Chem,2020,203:112627.
LIU Z H,LI J,XIA J,et al. Ginsenoside 20(S)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells[J]. Chem Biol Interact,2015,242:227-234.
THUST S C,HEILAND S,FALINI A,et al. Glioma ima-ging in Europe:a survey of 220 centres and recommendations for best clinical practice[J]. Eur Radiol,2018,28(8):3306-3317.
WEICHERT W. HDAC expression and clinical prognosis in human malignancies[J]. Cancer Lett,2009,280(2):168-176.
MAO G X,MU Z M,WU D. Exosome-derived miR-2682-5p suppresses cell viability and migration by HDAC1-silence-mediated upregulation of ADH1A in non-small cell lung cancer[J]. Hum Exp Toxicol,2021,40(12_suppl):S318-S330.
RIVAS M,2ndJOHNSTON M E,GULATI R,et al. HDAC1-dependent repression of markers of hepatocytes and P21 is involved in development of pediatric liver cancer[J]. Cell Mol Gastroenterol Hepatol,2021,12(5):1669-1682.
YANG W B,HSU C C,HSU T I,et al. Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma[J]. Neuro Oncol,2020,22(10):1439-1451.
刘雪文,杨锐,赵红艳,等. 重楼皂苷Ⅰ直接靶向STAT3抑制神经胶质瘤U251细胞增殖并诱导凋亡[J]. 肿瘤,2020,40(3):163-171.
LIU X W,YANG R,ZHAO H Y,et al. PolyphyllinⅠ directly targets STAT3 to inhibit proliferation of glioma U251 cells and induce apoptosis[J]. Tumor,2020,40(3):163-171.
夏菁,陈地龙,左国伟,等. 人参皂苷Rh2对人红白血病K562细胞HDAC1/2活性和周期蛋白的影响[J]. 细胞与分子免疫学杂志,2014,30(10):1062-1066.
XIA J,CHEN D L,ZUO G W,et al. Regulatory effect of ginsenoside Rh2 on HDAC1/2 activity and cyclin in human erythroleukemia K562 cells[J]. Chin J Cell Mol Immunol,2014,30(10):1062-1066.
NAKAGAWA M,ODA Y,EGUCHI T,et al. Expression profile of class Ⅰ histone deacetylases in human cancer tissues[J]. Oncol Rep,2007,18(4):769-774.
石雪萍,李静,冉建华,等. 人参皂苷Rh2调控PI3K/AKT/GSK-3β信号通路诱导人结肠癌细胞凋亡[J]. 中国药理学通报,2017,33(1):114-119.
SHI X P,LI J,RAN J H,et al. Ginsenoside Rh2 induced human colorectal cancer cell apoptosis through PI3K/AKT/GSK-3β pathway[J]. Chin Pharmacol Bull,2017,33(1):114-119.
林思,朱华,秦慧真,等. 对叶百部总生物碱对人肝癌SMMC-7721细胞凋亡及Bcl-2,Bax和cleaved caspase-3蛋白表达的影响[J]. 中国实验方剂学杂志,2021,27(19):73-79.
LIN S,ZHU H,QIN H Z,et al. Effect of Stemona tuberosa alkaloids on apoptosis of SMMC-7721 cells and expression of Bcl-2,Bax,and cleaved caspase-3[J]. Chin J Exp Tradit Med Formulae,2021,27(19):73-79.
冯健愉,朱玉山,陈佺,等. Bcl-2家族蛋白的生理功能及结构基础[J]. 中国细胞生物学学报,2019,41(8):1477-1489.
FENG J Y,ZHU Y S,CHEN Q,et al. Physiological function and structural basis of Bcl-2 family proteins[J]. Chin J Cell Biol,2019,41(8):1477-1489.
WANG W M,LIU Y Z,ZHAO L. Tambulin targets histone deacetylase 1 inhibiting cell growth and inducing apoptosis in human lung squamous cell carcinoma[J]. Front Pharmacol,2020,11:1188.
0
Views
3
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution